While the homozygous deletion of VPS35 in mice results in early embryonic lethality, VPS35 haploinsufficiency has been reported to enhance Alzheimer's disease (AD)-like neuropathology in a mouse model of AD (28). This evidence concerns the gene VPS35 and Alzheimer disease.